What are the manufacturers of tepotinib?

Tepotinib (tepotinib) is a methionine tyrosine kinase inhibitor used to treat various methionine-overexpressing non-small cell lung cancer . It was originally developed by EMD Serono Corporation and M.D. University of Texas. Developed in cooperation with Anderson Cancer Center in 2009, it has since been studied in the treatment of neuroblastoma, gastric cancer, non-small cell lung cancer and hepatocellular carcinoma. The price of each box is around 80,000 yuan (the price may fluctuate due to the exchange rate), and is produced by Laos The price of each box of Tepotinib generics produced by pharmaceutical factories is around RMB 8,600 (the price may fluctuate due to exchange rates). The ingredients of generic drugs produced abroad are basically the same as those of the original drugs.